PT Suparma Tbk (IDX:SPMA)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
278.00
+2.00 (0.72%)
Aug 5, 2025, 2:44 PM WIB

The AZEK Company Statistics

Total Valuation

PT Suparma Tbk has a market cap or net worth of IDR 870.53 billion. The enterprise value is 1.37 trillion.

Market Cap870.53B
Enterprise Value 1.37T

Important Dates

The last earnings date was Monday, July 28, 2025.

Earnings Date Jul 28, 2025
Ex-Dividend Date n/a

Share Statistics

PT Suparma Tbk has 3.15 billion shares outstanding.

Current Share Class 3.15B
Shares Outstanding 3.15B
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 81.58%
Owned by Institutions (%) 0.02%
Float n/a

Valuation Ratios

The trailing PE ratio is 7.99.

PE Ratio 7.99
Forward PE n/a
PS Ratio 0.32
PB Ratio 0.36
P/TBV Ratio 0.36
P/FCF Ratio 1.48
P/OCF Ratio 1.41
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.99, with an EV/FCF ratio of 2.34.

EV / Earnings 12.61
EV / Sales 0.50
EV / EBITDA 4.99
EV / EBIT 8.84
EV / FCF 2.34

Financial Position

The company has a current ratio of 2.37, with a Debt / Equity ratio of 0.27.

Current Ratio 2.37
Quick Ratio 0.59
Debt / Equity 0.27
Debt / EBITDA 2.43
Debt / FCF 1.14
Interest Coverage 4.67

Financial Efficiency

Return on equity (ROE) is 4.53% and return on invested capital (ROIC) is 3.17%.

Return on Equity (ROE) 4.53%
Return on Assets (ROA) 2.81%
Return on Invested Capital (ROIC) 3.17%
Return on Capital Employed (ROCE) 5.38%
Revenue Per Employee 3.33B
Profits Per Employee 132.15M
Employee Count808
Asset Turnover 0.79
Inventory Turnover 2.41

Taxes

In the past 12 months, PT Suparma Tbk has paid 30.81 billion in taxes.

Income Tax 30.81B
Effective Tax Rate 22.06%

Stock Price Statistics

The stock price has decreased by -6.67% in the last 52 weeks. The beta is 0.57, so PT Suparma Tbk's price volatility has been lower than the market average.

Beta (5Y) 0.57
52-Week Price Change -6.67%
50-Day Moving Average 264.64
200-Day Moving Average 283.71
Relative Strength Index (RSI) 63.39
Average Volume (20 Days) 380,925

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, PT Suparma Tbk had revenue of IDR 2.74 trillion and earned 108.89 billion in profits. Earnings per share was 34.52.

Revenue2.74T
Gross Profit 382.07B
Operating Income 155.36B
Pretax Income 139.71B
Net Income 108.89B
EBITDA 269.49B
EBIT 155.36B
Earnings Per Share (EPS) 34.52
Full Income Statement

Balance Sheet

The company has 165.45 billion in cash and 668.53 billion in debt, giving a net cash position of -503.07 billion or -159.50 per share.

Cash & Cash Equivalents 165.45B
Total Debt 668.53B
Net Cash -503.07B
Net Cash Per Share -159.50
Equity (Book Value) 2.44T
Book Value Per Share 772.88
Working Capital 848.19B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 618.34 billion and capital expenditures -30.51 billion, giving a free cash flow of 587.83 billion.

Operating Cash Flow 618.34B
Capital Expenditures -30.51B
Free Cash Flow 587.83B
FCF Per Share 186.37
Full Cash Flow Statement

Margins

Gross margin is 13.93%, with operating and profit margins of 5.67% and 3.97%.

Gross Margin 13.93%
Operating Margin 5.67%
Pretax Margin 5.09%
Profit Margin 3.97%
EBITDA Margin 9.83%
EBIT Margin 5.67%
FCF Margin 21.44%

Dividends & Yields

This stock pays an annual dividend of 12.00, which amounts to a dividend yield of 4.35%.

Dividend Per Share 12.00
Dividend Yield 4.35%
Dividend Growth (YoY) n/a
Years of Dividend Growth 4
Payout Ratio 34.68%
Buyback Yield n/a
Shareholder Yield 4.41%
Earnings Yield 12.51%
FCF Yield 67.53%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 15, 2022. It was a forward split with a ratio of 1.13.

Last Split Date Jun 15, 2022
Split Type Forward
Split Ratio 1.13

Scores

PT Suparma Tbk has an Altman Z-Score of 2.2 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.2
Piotroski F-Score 6